EE359 Cost-Utility of Bictegravir/Tenofovir Alafenamide/Emtricitabine in Naive Patients over 18 Years of Age Living with Human Immunodeficiency Virus Type 1 Infection, from the Colombian’s Health System Perspective
Abstract
Authors
E. Vásquez P. Lasalvia D. Rosselli W. Lenis D. Barbosa M.H. Díaz-Ortega